| Trial ID: | L2790 |
| Source ID: | NCT03066089
|
| Associated Drug: |
Fenfuro
|
| Title: |
Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Fenfuro
|
| Outcome Measures: |
Primary: Change in Fasting Blood Sugar, On completion of treatment (i.e.12 weeks) as compared to baseline|Change in Postprandial sugar, On completion of treatment (i.e.12 weeks) as compared to baseline | Secondary: Change in HbA1c levels, On completion of treatment (i.e.12 weeks) as compared to baseline|SGPT,SGOT,ALP,Creatinine,TLC,DLC & Hb, On completion of treatment (i.e.12 weeks) as compared to baseline
|
| Sponsor/Collaborators: |
Sponsor: Chemical Resources
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
104
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
|
| Start Date: |
2015-12-14
|
| Completion Date: |
2017-10
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-31
|
| Locations: |
Gian Sagar Medical College & Hospital, Rajpura, Punjab, 140601, India
|
| URL: |
https://clinicaltrials.gov/show/NCT03066089
|
